(1 - 15 von 24
)
Tiefer Aktienkurs keine grosse Gefahr - Handelszeitung
www.handelszeitung.ch
Neue Investoren stehen laut CEO Luca Benatti bereits bereit. Benatti will auch sein Verbindungsbüro in Basel personell ausbauen.
Newron to grant safinamide license to Meiji Seika Pharma ...
pipelinereview.com
Luca Benatti, CEO of Newron, said: We are excited to have reached agreement with Meiji Seika Pharma so soon after initiating talks to re-partner the safinamide rights, and we are looking forward very much to the collaboration with our new partner. We are in ongoing talks on other territories and anticipate further news on this in due course.
Newron: Interesse an Safinamide groß
www.finanznachrichten.de
Newrons Chief Executive Officer (CEO) Luca Benatti gab sich zuversichtlich über die Ergebnisse der laufenden Phase-III-Tests für Safinamide.
Sofinnova Partners leads EryDel's €26.5 million financingwww.sofinnovapartners.com › news › sofinnova-par...
sofinnovapartners.com
Luca Benatti, CEO of EryDel, indicates: “We are thrilled to welcome Sofinnova Partners as our lead investor. Their unique international reach and recognized ...
sortiert nach Relevanz / Datum